Ga direct naar de hoofdinhoud
Bone Marrow Browser
Bone Marrow Browser
Home
De Jong 2021
De Jong 2024
Kellermayer 2024
Korst and Tahri 2025
Fokkema and Bertamini 2025
Links
Circulating tumor cells in myeloma are a compound biomarker for bone marrow high-risk genomic alterations and tumor load
Under review 2025
Collaborative effort from
Myeloma Research Rotterdam
and
Myeloma lab Amsterdam UMC
Bone marrow NK cells:
NDMM vs. Control
Bone marrow NK cells:
NDMM CD38-positive NK cells
Bone marrow NK cells:
NDMM CD38-negative NK cells
Download CellRanger files for offline analysis